miR-20b regulates expression of proteinase-activated receptor-1 (PAR-1) thrombin receptor in melanoma cells

Pigment Cell and Melanoma Research

Volumn 27, Issue 3, 2014, Pages 431-441

  Saleiban, Amina ^a   Faxälv, Lars ^a   Claesson, Kjersti ^a   Jönsson, Jan Ingvar ^a   Osman, Abdimajid ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Department of Clinical Immunology and Transfusion Medicine   (Sweden)

Author keywords

Gene expression regulation; Melanoma; Metastasis; MicroRNAs; Proteinase activated receptor 1

Indexed keywords

CALCIUM; LUCIFERASE; MICRORNA; MICRORNA 106A; MICRORNA 106B; MICRORNA 20B; MICRORNA 93; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MESSENGER RNA; MIRN20 MICRORNA, HUMAN; RNA; TUMOR PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; BASE PAIRING; CALCIUM SIGNALING; CALCIUM TRANSPORT; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DENSITOMETRY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LENTIVIRINAE; MELANOMA; MELANOMA CELL; METASTATIC MELANOMA; PRIMARY MELANOMA; PRIMARY TUMOR; REPORTER GENE; SIGNAL NOISE RATIO; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; RNA PROCESSING; SECONDARY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; CALCIUM SIGNALING; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, REPORTER; HUMANS; MELANOMA; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RECEPTOR, PAR-1; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; RNA, NEOPLASM; THROMBIN;

EID: 84898639126     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12217     Document Type: Article

References (57)

1. Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
2. Bartel, D.P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233.
3. Cascio, S., D'andrea, A., Ferla, R., Surmacz, E., Gulotta, E., Amodeo, V., Bazan, V., Gebbia, N., and Russo, A. (2010). miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J. Cell. Physiol. 224, 242-249.
4. Coughlin, S.R. (2000). Thrombin signalling and protease-activated receptors. Nature 407, 258-264.
5. Dweep, H., Sticht, C., Pandey, P., and Gretz, N. (2011). miRWalk-database: prediction of possible miRNA binding sites by 'walking' the genes of three genomes. J. Biomed. Inform. 44, 839-847.
6. Esquela-Kerscher, A., and Slack, F.J. (2006). Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269.
7. Fabian, M.R., Sonenberg, N., and Filipowicz, W. (2010). Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79, 351-379.
8. Fassina, A., Marino, F., Siri, M., Zambello, R., Ventura, L., Fassan, M., Simonato, F., and Cappellesso, R. (2012). The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies. Lab. Invest. 92, 1574-1582.
9. Fischer, E.G., Ruf, W., and Mueller, B.M. (1995). Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells. Cancer Res. 55, 1629-1632.
10. Garcia-Lopez, M.T., Gutierrez-Rodriguez, M., and Herranz, R. (2010). Thrombin-activated receptors: promising targets for cancer therapy? Curr. Med. Chem. 17, 109-128.
11. Gedeon, T., and Bokes, P. (2012). Delayed protein synthesis reduces the correlation between mRNA and protein fluctuations. Biophys. J. 103, 377-385.
12. Greenbaum, D., Colangelo, C., Williams, K., and Gerstein, M. (2003). Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol. 4, 117.
13. Gygi, S.P., Rochon, Y., Franza, B.R., and Aebersold, R. (1999). Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19, 1720-1730.
14. Hayashita, Y., Osada, H., Tatematsu, Y., Yamada, H., Yanagisawa, K., Tomida, S., Yatabe, Y., Kawahara, K., Sekido, Y., and Takahashi, T. (2005). A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 65, 9628-9632.
15. He, L., Thomson, J.M., Hemann, M.T. et al. (2005). A microRNA polycistron as a potential human oncogene. Nature 435, 828-833.
16. Hemker, H.C., Giesen, P., Al Dieri, R., Regnault, V., De Smedt, E., Wagenvoord, R., Lecompte, T., and Beguin, S. (2003). Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol. Haemost. Thromb. 33, 4-15.
17. Hossain, A., Kuo, M.T., and Saunders, G.F. (2006). Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol. Cell. Biol. 26, 8191-8201.
18. Huntzinger, E., and Izaurralde, E. (2011). Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 12, 99-110.
19. Hutvagner, G., and Simard, M.J. (2008). Argonaute proteins: key players in RNA silencing. Nat. Rev. Mol. Cell Biol. 9, 22-32.
20. Iorio, M.V., and Croce, C.M. (2009). MicroRNAs in cancer: small molecules with a huge impact. J. Clin. Oncol. 27, 5848-5856.
21. Kahn, M.L., Nakanishi-Matsui, M., Shapiro, M.J., Ishihara, H., and Coughlin, S.R. (1999). Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J. Clin. Invest. 103, 879-887.
22. Kaufmann, R., and Hollenberg, M.D. (2012). Proteinase-activated receptors (PARs) and calcium signaling in cancer. Adv. Exp. Med. Biol. 740, 979-1000.
23. Klepfish, A., Greco, M.A., and Karpatkin, S. (1993). Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix. Int. J. Cancer 53, 978-982.
24. Kwak, P.B., Iwasaki, S., and Tomari, Y. (2010). The microRNA pathway and cancer. Cancer Sci. 101, 2309-2315.
25. Landais, S., Landry, S., Legault, P., and Rassart, E. (2007). Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res. 67, 5699-5707.
26. Lei, Z., Li, B., Yang, Z., Fang, H., Zhang, G.M., Feng, Z.H., and Huang, B. (2009). Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS ONE 4, e7629.
27. Leidinger, P., Keller, A., Borries, A., Reichrath, J., Rass, K., Jager, S.U., Lenhof, H.P., and Meese, E. (2010). High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer 10, 262.
28. Li, F., Baykal, D., Horaist, C., Yan, C.N., Carr, B.N., Rao, G.N., and Runge, M.S. (1996). Cloning and identification of regulatory sequences of the human thrombin receptor gene. J. Biol. Chem. 271, 26320-26328.
29. Liu, Q., and Paroo, Z. (2010). Biochemical principles of small RNA pathways. Annu. Rev. Biochem. 79, 295-319.
30. Melnikova, V.O., and Bar-Eli, M. (2009). Inflammation and melanoma metastasis. Pigment Cell Melanoma Res. 22, 257-267.
31. Melnikova, V.O., Dobroff, A.S., Zigler, M., Villares, G.J., Braeuer, R.R., Wang, H., Huang, L., and Bar-Eli, M. (2010). CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma. PLoS ONE 5, e12452.
32. Milsom, C., Yu, J., May, L. et al. (2007). The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression. Thromb. Res. 120(Suppl 2), S82-S91.
33. Mueller, B.M., Reisfeld, R.A., Edgington, T.S., and Ruf, W. (1992). Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc. Natl. Acad. Sci. U S A. 89, 11832-11836.
34. Murray, J.C. (1991). Coagulation and cancer. Br. J. Cancer 64, 422-424.
35. Nierodzik, M.L., Kajumo, F., and Karpatkin, S. (1992). Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res. 52, 3267-3272.
36. Nierodzik, M.L., Chen, K., Takeshita, K., Li, J.J., Huang, Y.Q., Feng, X.S., D'andrea, M.R., Andrade-Gordon, P., and Karpatkin, S. (1998). Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood 92, 3694-3700.
37. Osman, A., and Fälker, K. (2011). Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets 22, 433-441.
38. Ota, A., Tagawa, H., Karnan, S., Tsuzuki, S., Karpas, A., Kira, S., Yoshida, Y., and Seto, M. (2004). Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64, 3087-3095.
39. Paredes, R.M., Etzler, J.C., Watts, L.T., Zheng, W., and Lechleiter, J.D. (2008). Chemical calcium indicators. Methods 46, 143-151.
40. Provost, P., Dishart, D., Doucet, J., Frendewey, D., Samuelsson, B., and Radmark, O. (2002). Ribonuclease activity and RNA binding of recombinant human Dicer. EMBO J. 21, 5864-5874.
41. Rao, L.V. (1992). Tissue factor as a tumor procoagulant. Cancer Metastasis Rev. 11, 249-266.
42. Reuland, S.N., Smith, S.M., Bemis, L.T., Goldstein, N.B., Almeida, A.R., Partyka, K.A., Marquez, V.E., Zhang, Q., Norris, D.A., and Shellman, Y.G. (2013). MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD). J. Invest. Dermatol. 133, 1286-1293.
43. Rickles, F.R., and Edwards, R.L. (1983). Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 62, 14-31.
44. Tellez, C., Mccarty, M., Ruiz, M., and Bar-Eli, M. (2003). Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma. J. Biol. Chem. 278, 46632-46642.
45. Thomson, D.W., Bracken, C.P., and Goodall, G.J. (2011). Experimental strategies for microRNA target identification. Nucleic Acids Res. 39, 6845-6853.
46. Varki, A. (2007). Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 110, 1723-1729.
47. Versteeg, H.H., Spek, C.A., Peppelenbosch, M.P., and Richel, D.J. (2004). Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Mol. Med. 10, 6-11.
48. Villares, G.J., Zigler, M., and Bar-Eli, M. (2011a). The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis-a possible therapeutic target. Oncotarget 2, 8-17.
49. Villares, G.J., Zigler, M., Dobroff, A.S., Wang, H., Song, R., Melnikova, V.O., Huang, L., Braeuer, R.R., and Bar-Eli, M. (2011b). Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype. Proc. Natl. Acad. Sci. U S A. 108, 626-631.
50. Volinia, S., Calin, G.A., Liu, C.G. et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U S A. 103, 2257-2261.
51. Vu, T.K., Hung, D.T., Wheaton, V.I., and Coughlin, S.R. (1991). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068.
52. Xu, Y., Brenn, T., Brown, E.R., Doherty, V., and Melton, D.W. (2012). Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. Br. J. Cancer 106, 553-561.
53. Yi, R., Qin, Y., Macara, I.G., and Cullen, B.R. (2003). Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17, 3011-3016.
54. Yu, J.L., May, L., Lhotak, V., Shahrzad, S., Shirasawa, S., Weitz, J.I., Coomber, B.L., Mackman, N., and Rak, J.W. (2005). Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 105, 1734-1741.
55. Zhang, H., Kolb, F.A., Brondani, V., Billy, E., and Filipowicz, W. (2002). Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J. 21, 5875-5885.
56. Zhang, X., Yu, H., Lou, J.R., Zheng, J., Zhu, H., Popescu, N.I., Lupu, F., Lind, S.E., and Ding, W.Q. (2011). MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells. J. Biol. Chem. 286, 1429-1435.
57. Zwicker, J.I. (2010). Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. Thromb. Res. 125(Suppl 2), S89-S91.